De hyppigst rapporterede bivirkninger (medicinrelateret behandling- fremkommende) i kombinationsbehandling (Caelyx + bortezomib) var kvalme (40%), diarré (35%), neutropeni (33%), thrombocytopeni (29%), opkastning (28%), træthed (27%) og forstoppelse (22%).
9 (medicine-related treatment-emergent) adverse events in combination therapy (Caelyx + bortezomib) were nausea (40%), diarrhoea (35%), neutropaenia (33%), thrombocytopaenia (29%), vomiting (28%), fatigue (27%), and constipation (22%).